A historic change to guidelines for treating drug-resistant tuberculosis has been published by the World Health Organization.
List view / Grid view
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.
Researchers at Aston University and Birmingham Children’s Hospital, UK, have discovered a highly effective three-drug approach to treat Mycobacterium abscessus (M. abscessus), a notoriously drug-resistant pathogen that affects up to 13 percent of cystic fibrosis (CF) patients in the UK.
Center for Disease Dynamics, Economics & Policy researchers have mapped the geographical distribution of antibiotics after their market introduction...